Effect and Safety of Xueshuantong Combined with Conventional Western Medicine for Angina Pectoris in Coronary Heart Disease Patients: A Systematic Review
Ming-ming ZHAO,Hai-rong WANG,Feng XIONG,Chen NIE,You ZHOU
DOI: https://doi.org/10.7507/1002-0179.20150081
2015-01-01
Abstract:Objective To evaluate the ei cacy and safety of Xueshuantong combined with conventional western medicine for angina pectoris in coronary heart disease(CHD) patients. Methods We searched the Cochrane Library(2013.12), Medline(2013.10), EMbase(unlimited-2013.10), China Nation Knowledge Infrastructure(unlimited-2013.10) and the Wanfang Database(unlimitied-2013.10), Weipu Database(unlimited-2013.10), and CBM(unlimited-2013.10) on computers for parallel group randomized controlled trials(RCTs) comparing Xueshuantong and placebo for patients with angina pectoris. h ree researchers selected the trials based on the inclusion and exclusion criteria and then extracted the data, assessed the quality of each trial independently. At er cross checking, the Cochrane Collaborationu0027s Rev Man 5.1 sot ware was used to perform Meta-analysis. Results h irteen RCTs and a total of 1 298 participants were involved. Meta-analysis showed that Xueshuantong combined with the conventional western medicine had better curative ef ect on angina pectoris for CHD than conventional therapy; stable angina pectoris [RR=1.24, 95%CI(1.12, 1.37), P 0.000 1];unstable angina pectoris [RR=1.22, 95%CI(1.15, 1.29), P 0.000 01]. There was also significant difference in total curative effect between the two groups [RR=1.22, 95%CI(1.16, 1.29), P 0.000 01]. Xueshuantong also had better curative ef ect on improving performance of electrocardiogtram(ECG): stable angina pectoris [RR=1.30, 95%CI(1.11, 1.51), P=0.000 8]; unstable angina pectoris [RR=1.18, 95%CI(1.10, 1.28), P 0.000 1]. There was also significant dif erence in total curative ef ect on improving performance of ECG between the two groups [RR=1.21, 95%CI(1.13, 1.29), P 0.000 01]. But there was no signii cant dif erence in adverse ef ects rate between the two groups [RR=4.50, 95%CI(0.99, 20.53), P=0.05]. Conclusions Compared with conventional therapy, Xueshuantong combined with conventional western medicine has better curative ef ect with improved performance of ECG. h e adverse ef ect rate between the two groups is not signii cantly dif erent. But because of the small scale, inferior quality, and bias risk of these trials, large-scale, rational designed, multicenter RCTs are needed to coni rm our conclusions.